Excimer Laser Therapy

Excimer Laser Basics - Zap & Soothe

• Definition: Xenon Chloride (XeCl) laser emitting monochromatic Ultraviolet B (UVB) light at 308 nm.
• Mechanism of Action:
  • Immunomodulation: Induces apoptosis of pathogenic T-lymphocytes; ↓ T-cell infiltration & pro-inflammatory cytokines (e.g., IFN-γ, TNF-α).
  • Melanogenesis stimulation: Promotes melanocyte proliferation and migration in vitiligo.
  • DNA effects: Causes cell cycle arrest and apoptosis in targeted cells.

⭐ The 308 nm wavelength is crucial for its targeted effect, inducing T-cell apoptosis with minimal collateral damage to healthy tissue.

Laser Targets - Who Gets Zapped?

The 308 nm Excimer laser offers targeted UVB, ideal for localized, therapy-resistant dermatoses, sparing uninvolved skin.

• FDA-Approved Indications: (📌 P-V-A)
  • Psoriasis: Localized, recalcitrant plaques (scalp, palms, soles); fewer sessions than NB-UVB.
  • Vitiligo: Stable segmental, focal, or limited non-segmental; effective on face/neck.
  • Atopic Dermatitis: Chronic, localized, lichenified lesions; steroid-sparing option.
• Common Off-Label Uses (Evidence Varies):
  • Alopecia Areata: Patchy, persistent areas.
  • Mycosis Fungoides: Early patch/plaque stage (e.g., Stage IA, IB).
  • Lichen Planus: Hypertrophic cutaneous, oral erosive.
  • Hypopigmented scars: To improve pigmentation.

⭐ Excimer laser excels with localized, recalcitrant psoriatic plaques and stable vitiligo, often showing rapid response.

Contraindications - When Not to Zap

• Absolute:
  • History of melanoma or multiple non-melanoma skin cancers (NMSCs) in treatment area.
  • Xeroderma Pigmentosum.
  • Lupus Erythematosus (photosensitive forms).
  • Porphyria.
• Relative:
  • Active skin infections (e.g., herpes simplex).
  • Photosensitizing medications.
  • Pregnancy/Lactation (use with caution).
  • History of radiation therapy to the area.

⭐ A personal history of melanoma in or near the treatment area is an absolute contraindication for excimer laser therapy.

Treatment Protocol - Zap It Right

• Pre-treatment:
  • Thorough skin cleansing.
  • Patient counseling on procedure & expectations.
  • Mandatory eye protection (patient & operator).
• MED Determination & Initial Dose:
  • Perform MED testing: Apply test spots, read erythema after 24-72 hrs.
  • Psoriasis: Initial dose typically 1-2 MEDs.
  • Vitiligo: If MED not done, start with fixed low dose (e.g., 50-100 mJ/cm²).
• Treatment Parameters & Schedule:
  • Adjust spot size & fluence (mJ/cm²) as needed.
  • Frequency: 2-3 times/week for psoriasis/vitiligo.
  • Duration: Psoriasis 10-20 sessions; Vitiligo 20-30+ sessions.
• Dose Escalation:
  • Increase fluence by 10-20% each session if no adverse effects (e.g., blistering), guided by erythema.
• Post-treatment Care:
  • Advise strict sun protection.
  • Recommend emollients.

⭐ MED testing is crucial for psoriasis to optimize efficacy and minimize side effects; for vitiligo, starting doses (e.g., 50-100 mJ/cm²) are often standardized.

Zap's Aftermath - Side Effect Watch

• Common (Usually Transient):

  • Erythema (expected), mild pain/stinging, pruritus.
  • Blistering (dose-dependent, esp. vitiligo); manage: ↓dose, topical steroids.
  • Hyperpigmentation (esp. darker skin).

• Less Common/Rare:

  • Hypopigmentation.
  • Koebner phenomenon.
  • Herpes simplex reactivation.

• Long-term Risks (Low with Targeted Therapy):

  • Theoretically, carcinogenesis (UVB spectrum).
  • Photoaging.

⭐ Blistering is a common dose-dependent side effect, particularly in vitiligo treatment, managed by dose reduction or temporary cessation and topical steroids for severe cases.

High‑Yield Points - ⚡ Biggest Takeaways

• Excimer laser delivers 308 nm (XeCl) monochromatic UVB, targeting affected skin.
• Mechanism involves T-cell apoptosis, immunomodulation, and melanocyte stimulation.
• Prime indications: Localized psoriasis, segmental/focal vitiligo, alopecia areata.
• Benefits: Spares healthy tissue, offers quicker results for localized disease.
• Side effects: Typically mild; erythema, blistering, transient hyperpigmentation.
• Highly effective for stable, localized vitiligo and resistant psoriatic plaques.
• Avoid in patients with history of skin cancer or photosensitive conditions.